University of Calgary

University / College


Location: Calgary, Canada (CA) CA

ISNI: 0000000419367697

ROR: https://ror.org/03yjb2x39

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

The Immune Landscape of Cancer. (2019) Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Yang THO, Porta-Pardo E, et al. Journal article, Erratum The ASKAP EMU early Science project: Radio continuum survey of the Small Magellanic Cloud (2019) Joseph TD, Filipović MD, Crawford EJ, Bojičić I, Alexander EL, Wong GF, Andernach H, et al. Journal article, Review article Gout, hyperuricaemia and crystal-associated disease network (G-CAN) consensus statement regarding labels and definitions of disease states of gout (2019) Bursill D, Taylor WJ, Terkeltaub R, Abhishek A, So AK, Vargas-Santos AB, Gaffo AL, et al. Journal article Anelastic reorganisation of fibre-reinforced biological tissues (2019) Di Stefano S, Carfagna M, Knodel M, Hashlamoun K, Federico S, Grillo A Journal article Gata6+ Pericardial Cavity Macrophages Relocate to the Injured Heart and Prevent Cardiac Fibrosis (2019) Deniset JF, Belke D, Lee WY, Jorch SK, Deppermann C, Hassanabad AF, Turnbull JD, et al. Journal article Opposite dynamics of GABA and glutamate levels in the occipital cortex during visual processing (2018) Kurcyus K, Annac E, Hanning NM, Harris AD, Oeltzschner G, Edden R, Riedl V Journal article Tumor-infiltrating CD8-positive T-lymphocytes in tubo-ovarian high-grade serous cancer are associated with multiple germline variants in 22q12.1 in a genome-wide association analysis (2018) Natanzon Y, Kobel M, Winham SJ, Armasu SM, Mccauley BM, Vierkant RA, Cunningham JM, et al. Conference contribution Treatment efficacyand safety of seladelpar, a selective peroxisome proliferator-activated receptor delta agonist, in primary biliary cholangitis patients: 12-and 26-week analysis from an ongoing international, randomized, dose raging phase 2 study (2018) Hirschfield G, Boudes P, Bowlus C, Gitlin N, Michael G, Harrison S, Gordon SC, et al. Conference contribution Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers. (2018) Peng X, Chen Z, Farshidfar F, Xu X, Lorenzi PL, Wang Y, Cheng F, et al. Journal article Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. (2018) Liu Y, Sethi NS, Hinoue T, Schneider BG, Cherniack AD, Sanchez-Vega F, Seoane JA, et al. Journal article